Barson Corporation is a business incubator and holding company with a focus on investing in new technologies and organizations working with high-performance materials. These materials are used in aerospace, biomaterials, medical devices, and pharmaceutical delivery. The company's portfolio includes Hitemco, specializing in high-performance surface treatments, Himed, focusing on medical surfaces and calcium-based biomaterials, and SAVSU Technologies, a provider of state-of-the-art vaccine transport devices, which was sold to BioLife Solutions in 2019.
The main markets for Barson Corporation's portfolio companies include aerospace, energy, medical, and dental sectors. Across these sectors, the common theme is a commitment to improving everyday life through the advancement of high-performance technologies. Founded in 1974, Barson Corporation has demonstrated a sustained interest in cutting-edge innovations in various industries. However, specific information about the industries in which it operates and its headquarters is not available at this time.
As per the available data, the details regarding the last investment and the involved investors are not specified. Despite this, it is clear that Barson Corporation has focused its investments on companies contributing to the development and application of high-performance materials in diverse fields, making it a compelling entity for potential venture capital interest.
There is no investment information
No recent news or press coverage available for Barson Corporation.
We care about your data, and we'd love to use cookies make your experience better.
